1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Aurion Biotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction Combination Product: AURN001 + Y-27632, Placebo - Corneal Edema, Corneal Endothelial Dysfunction | Phase 3 | Active not recruiting | Aurion Biotech | 130 | 2026-02-19 | 2026-09-24 |
Corneal Edema (1)
Y 27632 (1)
United States (1)